tiprankstipranks
Catalyst Pharma Highlights Growth in Rare Diseases Sector
PremiumCompany AnnouncementsCatalyst Pharma Highlights Growth in Rare Diseases Sector
1M ago
Catalyst Pharmaceuticals price target raised to $31 from $29 at Oppenheimer
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $31 from $29 at Oppenheimer
1M ago
Catalyst Pharmaceuticals price target raised to $35 from $30 at H.C. Wainwright
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $35 from $30 at H.C. Wainwright
1M ago
Catalyst Pharmaceuticals reports settlement of Firdapse patent litigation with Teva
PremiumThe FlyCatalyst Pharmaceuticals reports settlement of Firdapse patent litigation with Teva
1M ago
Catalyst Pharmaceuticals trading halted, news pending
Premium
The Fly
Catalyst Pharmaceuticals trading halted, news pending
1M ago
Catalyst Pharmaceuticals management to meet with Truist
Premium
The Fly
Catalyst Pharmaceuticals management to meet with Truist
2M ago
Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
PremiumThe FlyClosing Bell Movers: AppLoving up 29% after Q3 earnings beat
4M ago
Catalyst Pharmaceuticals reports Q3 non-GAAP EPS 57c, consensus 30c
Premium
The Fly
Catalyst Pharmaceuticals reports Q3 non-GAAP EPS 57c, consensus 30c
4M ago
Catalyst Pharmaceuticals sees FY24 revenue $475M-$485M, consensus $473.67M
Premium
The Fly
Catalyst Pharmaceuticals sees FY24 revenue $475M-$485M, consensus $473.67M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100